Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $212M invested in Corvus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 13 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
22
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
1
EcoR1 Capital
San Francisco,
California
|
$9.74M |
| 2 |
2
Jennison Associates
New York
|
$12.3M |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$3.32M |
| 4 |
4
BlackRock
New York
|
$4.47M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$4.03M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACA
51
Avoro Capital Advisors
New York
| – | -$2.53M | -121,715 | Closed |
|
|
CAM
52
Cormorant Asset Management
Boston,
Massachusetts
| – | -$1.68M | -81,000 | Closed |
|
|
SAM
53
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$1.4M | -67,200 | Closed |
|
|
DM
54
Deerfield Management
New York
| – | -$767K | -36,931 | Closed |
|
|
EIM
55
Essex Investment Management
Boston,
Massachusetts
| – | -$649K | -31,225 | Closed |
|
56
Millennium Management
New York
| – | -$475K | -22,853 | Closed |
|
|
TC
57
TFS Capital
West Chester,
Pennsylvania
| – | -$356K | -17,125 | Closed |
|
|
PCM
58
Prelude Capital Management
New York
| – | -$308K | -14,852 | Closed |
|
|
OAM
59
Oxford Asset Management
Oxford,
United Kingdom
| – | -$287K | -13,809 | Closed |
|
|
ECM
60
Endurant Capital Management
San Mateo,
California
| – | -$282K | -13,600 | Closed |
|
|
CSS
61
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$30K | -1,429 | Closed |
|
62
UBS Group
Zurich,
Switzerland
| – | -$15K | -698 | Closed |
|